Stock Markets News

Why is Cigna stock climbing today?

By Investing.com2 min readInvesting.com
Why is Cigna stock climbing today?Why is Cigna stock climbing today?

Why is Cigna stock climbing today?

Cigna Corp stock rose 2.2% in pre-open trading after the health services giant delivered a third-quarter earnings beat and lifted its full-year profit guidance ahead of the regular session.

Adjusted earnings per share came in at $7.98 for the quarter, clearing the $7.52 analyst consensus by a meaningful margin, while revenue of $73.7 billion grew 6% from the prior year and topped the $72.65 billion estimate.

The company also raised its 2026 full-year adjusted earnings outlook to at least $30.60 per share, a $0.15 increase from its prior projection and modestly above the $30.51 Wall Street consensus.

Cigna Healthcare, the insurance segment, posted 9% adjusted revenue growth, fueled by premium rate increases designed to offset rising medical costs, while Evernorth Health Services — which houses the pharmacy benefit management business — grew adjusted revenue 6%. The company additionally noted it had repurchased approximately $500 million worth of its own shares year-to-date, signaling continued capital return discipline.

The result arrived in a favorable sector environment. Peer managed-care companies had already set a constructive tone in recent weeks, with UnitedHealth raising its 2026 guidance following its own Q3 beat and Elevance Health similarly lifting its full-year outlook after stronger-than-expected results.

That positive read-through across the managed-care space helped amplify investor receptivity to Cigna’s print. On the broader market, the S&P 500 added 0.2% and the Dow Jones gained 0.7%, while the Nasdaq edged 0.5% lower, providing a mixed but generally supportive macro backdrop.

Taken together, a clean earnings beat, a guidance raise, and a sector-wide tailwind from peer results combined to push Cigna shares toward their 52-week high of $316.26, with the stock trading at $311.99 in pre-market activity and drawing renewed attention from investors who had been closely watching medical cost trends and Evernorth’s profitability trajectory heading into the print.